Minapharm Pharmaceuticals
🇪🇬Egypt
- Country
- 🇪🇬Egypt
- Ownership
- Public
- Established
- 1958-01-01
- Employees
- 1K
- Market Cap
- -
- Website
- http://www.minapharm.com
Study to Assess the Safety & Efficacy of Oral Ciprodiazole Versus Currently Used Ciprofloxacin & Metronidazole
Phase 4
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2023-05-18
- Last Posted Date
- 2023-05-18
- Lead Sponsor
- MinaPharm Pharmaceuticals
- Target Recruit Count
- 312
- Registration Number
- NCT05863832
- Locations
- 🇪🇬
Faculty of Medicine - Menofia University, Shibīn Al Kawm, Menofia, Egypt
Study to Compare the Efficacy & Safety of Ursoplus Capsules vs. UDCA vs. Placebo Among Chronic Liver Disease Patients
Phase 4
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2023-05-09
- Last Posted Date
- 2023-05-09
- Lead Sponsor
- MinaPharm Pharmaceuticals
- Target Recruit Count
- 297
- Registration Number
- NCT05849558
- Locations
- 🇪🇬
Air Force Specialized Hospital, Cairo, New Cairo, Egypt
Study Evaluation of Recombinant Hirudin in Prophylaxis of Post-Operative Deep Vein Thrombosis
- First Posted Date
- 2023-05-06
- Last Posted Date
- 2023-05-06
- Lead Sponsor
- MinaPharm Pharmaceuticals
- Target Recruit Count
- 100
- Registration Number
- NCT05847205
- Locations
- 🇪🇬
Alexandria University, Alexandria, Egypt
Gonapure® in Multifollicular Stimulation in Egyptian Women Undergoing IVF/ICSI
- First Posted Date
- 2017-02-20
- Last Posted Date
- 2017-08-30
- Lead Sponsor
- MinaPharm Pharmaceuticals
- Target Recruit Count
- 200
- Registration Number
- NCT03057574
- Locations
- 🇪🇬
Alexandria University, Alexandria, Egypt
🇪🇬Ain Shams University, Cairo, Egypt
Topical r-Hirudin ( Thrombexx ) Efficacy in Treatment of Haematomas
- First Posted Date
- 2013-10-10
- Last Posted Date
- 2013-10-10
- Lead Sponsor
- MinaPharm Pharmaceuticals
- Target Recruit Count
- 200
- Registration Number
- NCT01960569
- Locations
- 🇪🇬
Prof. Mahmoud Hafez, Cairo, Egypt
Trial Comparing the Efficacy, Tolerability and Safety Between Three Arms in Treatment of HCV in Egyptian Population
- First Posted Date
- 2013-07-11
- Last Posted Date
- 2013-07-11
- Lead Sponsor
- MinaPharm Pharmaceuticals
- Target Recruit Count
- 300
- Registration Number
- NCT01896609
- Locations
- 🇪🇬
Faculty of Medicine , Cairo University, Cairo, Egypt
Hansenula-derived Pegylated Interferon in Treatment of Patients With Chronic Hepatitis C
- First Posted Date
- 2012-07-25
- Last Posted Date
- 2013-01-15
- Lead Sponsor
- MinaPharm Pharmaceuticals
- Target Recruit Count
- 5000
- Registration Number
- NCT01649245
- Locations
- 🇪🇬
National Liver Institute, Shebin El-Kom, Menoufiya, Egypt
© Copyright 2024. All Rights Reserved by MedPath